Open AccessClinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2-Metastatic Breast Cancer
Author(s) -
Yan Song,
Yanni Hao,
Alexander R. Macalalad,
Peggy L. Lin,
James Signorovitch,
Eric Q. Wu
Publication year - 2015
Publication title -
breast cancer basic and clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.741
H-Index - 23
ISSN - 1178-2234
DOI - 10.4137/bcbcr.s30771
Subject(s) - metastatic breast cancer , medicine , oncology , chemotherapy , endocrine system , breast cancer , cancer , hormone
To describe patient profiles and clinical outcomes associated with first-line endocrine monotherapy (ET) and chemotherapy (CT) for postmenopausal HR+/HER2- metastatic breast cancer (mBC) patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom